Back to Glossary
Mechanism Definition

Competitive Inhibition

Also known as: competitive antagonism, competitive blocking

Competitive Inhibition A form of enzyme inhibition where the inhibitor competes with the substrate for the active site of an enzyme. The inhibitor resembles the substrate structurally and binds reversibly to the active site, preventing substrate binding but not altering the enzyme's maximum velocity at high substrate concentrations.

Last updated: February 1, 2026

What is Competitive Inhibition?

Competitive inhibition is a type of enzyme inhibition where an inhibitor molecule competes directly with the substrate for binding to the enzyme’s active site. Because both molecules cannot occupy the active site simultaneously, the inhibitor reduces enzyme activity by decreasing the probability of substrate binding. This inhibition is typically reversible and can be overcome by increasing substrate concentration.

How Competitive Inhibition Works

The mechanism follows predictable kinetic principles:

  1. Structural similarity: The inhibitor often resembles the substrate, allowing it to fit in the active site
  2. Reversible binding: The inhibitor binds and dissociates from the active site dynamically
  3. Concentration dependence: Higher substrate concentrations outcompete the inhibitor
  4. Kinetic effects: Increases apparent Km (reduces apparent affinity) while Vmax remains unchanged

This characteristic kinetic signature distinguishes competitive from other inhibition types.

Competitive Inhibitors in Peptide Research

Many peptide-based therapeutics utilize competitive inhibition:

  • ACE inhibitor peptides: Block angiotensin-converting enzyme to reduce blood pressure
  • DPP-4 substrate analogs: Compete with natural substrates to prolong incretin hormone activity
  • Protease inhibitors: Peptide-based HIV protease inhibitors compete with viral polyprotein substrates

Peptides make excellent competitive inhibitors due to their ability to mimic natural substrates.

Therapeutic Applications

Competitive inhibition is valuable in drug development because:

  • Predictable pharmacology: Effects are proportional to inhibitor concentration
  • Overcomeable: Excessive inhibition can be reversed by natural substrate accumulation
  • Selective targeting: Inhibitors can be designed to specifically fit target enzyme active sites

Limitations and Considerations

  • High concentrations needed: Must compete with endogenous substrate levels
  • Substrate accumulation: Rising substrate may reduce inhibitor effectiveness
  • Selectivity challenges: Similar enzymes may share active site features
  • Michaelis-Menten kinetics: Mathematical framework describing enzyme kinetics
  • Inhibition constant (Ki): Measure of inhibitor binding affinity
  • Substrate specificity: Enzyme selectivity for particular substrates

Related Terms

Non-Competitive Inhibition Enzyme Inhibition Substrate Binding

Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.